+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human colorectal cancer tissue using P05257(SYCP2 Antibody) at dilution 1/20. (Original magnification: ×200)    

  
  

The SYCP2 antibody targets the synaptonemal complex protein 2 (SYCP2), a key component of the synaptonemal complex (SC) essential for meiosis in eukaryotic cells. SYCP2. along with SYCP3. forms the lateral elements of the SC, a proteinaceous structure that mediates homologous chromosome pairing, recombination, and segregation during gametogenesis. SYCP2 is critical for SC assembly, stabilization, and the regulation of crossover formation. It interacts with other meiotic proteins, such as cohesins and recombination mediators, ensuring proper chromosomal synapsis and genomic integrity.

Research involving SYCP2 antibodies primarily focuses on studying meiotic processes, fertility disorders, and germ cell development. These antibodies are widely used in techniques like immunofluorescence, Western blotting, and immunohistochemistry to visualize SYCP2 localization during meiotic prophase I, particularly in spermatocytes and oocytes. Abnormalities in SYCP2 expression or function have been linked to meiotic arrest, non-obstructive azoospermia, and recurrent pregnancy loss, making it a biomarker of interest in reproductive medicine. Additionally, SYCP2 antibodies aid in exploring the molecular mechanisms of SC dynamics and their implications in aneuploidy or developmental defects. Commercial SYCP2 antibodies are typically validated in model organisms (e.g., mice, humans) to support both basic and clinical research in reproductive biology.